title: Erythropoietin provides a useful strategy for treating preoperative anemia in planned elective orthopedic surgery: an analysis of benefit in routine practice.
authors.forename: Moosa
authors.initials: M
authors.lastname: Qureshi
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Momoh
authors.forename: Marcus
authors.initials: M
authors.lastname: Bankes
authors.forename: Peter
authors.initials: P
authors.lastname: Earnshaw
authors.forename: Deepti
authors.initials: D
authors.lastname: Radia
authors.forename: Claire
authors.initials: C
authors.lastname: Harrison
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000188:drug therapy* / Q000453:epidemiology; D015331:Cohort Studies; D017558:Elective Surgical Procedures / Q000379:methods / Q000706:statistics & numerical data; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009985:Orthopedics / Q000379:methods / Q000706:statistics & numerical data; D011300:Preoperative Care / Q000379:methods*; D011364:Professional Practice / Q000706:statistics & numerical data; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D004921:Erythropoietin